HAE vs SNPS · P/E 35, rev $1.33B vs P/E 63, rev $7.16B
Haemonetics Corporation (HAE) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
Haemonetics Corporation (HAE) is a medical devices company listed on US.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
Latest reported HAE revenue for 2026-03-28 was $1.33B. Net income was $97.3M. Revenue was down 2.0% from 2025-03-29 to 2026-03-28. HAE currently screens at market cap $3.24B and trailing P/E 34.8.
Latest reported SNPS revenue for 2026-07-31 was $7.16B. Net income was $627.9M. Revenue was up 52.9% from 2026-04-30 to 2026-07-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
HAE currently screens at market cap $3.24B and trailing P/E 34.8. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the HAE and SNPS stock pages for the full models.
Not investment advice.